Use the Back button in your browser to see the other results of your search or to select another record.
Phase II randomized controlled trial of constraint-induced movement therapy in multiple sclerosis. Part 1: effects on real-world function |
Mark VW, Taub E, Uswatte G, Morris DM, Cutter GR, Adams TL, Bowman MH, McKay S |
Neurorehabilitation and Neural Repair 2018 Mar;32(3):223-232 |
clinical trial |
4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|